About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Palliative vs. Hospice Care & Benefits of Early Integration of Palliative Care for Patients with Leukemia
By
UNMC Leukemia Symposium: Focus on Opportunities to Improve Care
FEATURING
Melissa Teply
By
UNMC Leukemia Symposium: Focus on Opportunities to Improve Care
FEATURING
Melissa Teply
0 views
July 19, 2019
Comments
0
Login to view comments.
Click here to Login
Featured Video
24:08
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…
Feat.
A. Tefferi
Featured Video
24:35
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
Feat.
A. Tefferi
Recommended
AUTOPLAY
ON
Related
Newest
08:18
Insights from 2023 ASH Annual Meeting
Treatment Strategies for Hematocrit Control in PV
Feat.
A. Zhou
16:18
Masterclasses in Dermatology
Masterclasses from the Wards
Feat.
S. Elman
06:00
2024 Clinical Case Studies
Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration
Feat.
A. Geisler
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
09:27
ASH 2022 Conference Coverage
MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…
Feat.
M. McMullin
16:25
Northwestern Medicine Oncology and Hematology
Diagnosis and Goals of Therapy in PV
Feat.
B. Stein
06:51
Insights from 2023 ASH Annual Meeting
Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…
Feat.
D. Tremblay
51:20
Jerry Spivak
Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…
10:49
Monia Marchetti
Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
13:04
Alexander Coltoff
Symptomatic Profiles of Patients With Polycythemia Vera: Implication…
37:12
Tisch Cancer Institute at Mount Sinai
Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: 6…
Feat.
M. Metzger
10:44
Aaron Gerds
A Real-World Evaluation of the Association Between Elevated Blood Co…
10:27
Richard T. Silver
Splenomegaly in Polycythemia Vera: Clinical Significance and Relatio…
15:41
5th SOHO Italy Annual Conference
SOHO Italy 2023: WHO 2022 Classification of MPNs - Transitioning Fro…
Feat.
H. Hamed
28:25
Michael Deininger
The Role of Genomic Analysis and Panel Mutation Screening in the Con…
40:05
Tisch Cancer Institute at Mount Sinai
Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: M…
Feat.
D. Tremblay,
J. Mascarenhas,
R. Sheppard,
A. Shih,
I. Sarami
13:29
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Next Questions in ALL
Feat.
B. Shah
01:24
Total Health
ASCO 2022 Updates in Lymphoma and CLL
Feat.
W. Hammond
10:37
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Next Questions in CLL
Feat.
S. O'Brien
